The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Male Infertility Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Male infertility treatment includes medical interventions and therapies aimed at addressing fertility issues in men, such as sperm quality, quantity, and motility problems.
The global Male Infertility Treatment market size is expected to reach US$ 2229.8 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Male Infertility Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Male Infertility Treatment market. DNA Fragmentation Technique, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxidative Stress Analysis segment is estimated at % CAGR for the next seven-year period.
The market for male infertility treatment is driven by factors such as the increasing prevalence of male infertility and the growing awareness about fertility treatments for men. The market's growth is also influenced by ongoing research and development in reproductive medicine.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Male Infertility Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Male Infertility Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Male Infertility Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Male Infertility Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Male Infertility Treatment covered in this report include Merck Serono, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions and Livzon Pharmaceutical Group Inc., etc.
The global Male Infertility Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Serono
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions
Livzon Pharmaceutical Group Inc.
Zhejiang Xianju Pharmaceutical Co.,Ltd.
GeneScience Pharmaceuticals Co., Ltd.
Abeona Therapeutics Inc.
ASKA Pharmaceutical Co., Ltd.
Bristol Myers Squibb
Church & Dwight
Intas Biopharmaceuticals
Eli Lilly and Company
Global Male Infertility Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Male Infertility Treatment market, Segment by Type:
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Global Male Infertility Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Male Infertility Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Male infertility treatment includes medical interventions and therapies aimed at addressing fertility issues in men, such as sperm quality, quantity, and motility problems.
The global Male Infertility Treatment market size is expected to reach US$ 2229.8 million by 2029, growing at a CAGR of 7.9% from 2023 to 2029. The market is mainly driven by the significant applications of Male Infertility Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Male Infertility Treatment market. DNA Fragmentation Technique, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oxidative Stress Analysis segment is estimated at % CAGR for the next seven-year period.
The market for male infertility treatment is driven by factors such as the increasing prevalence of male infertility and the growing awareness about fertility treatments for men. The market's growth is also influenced by ongoing research and development in reproductive medicine.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Male Infertility Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Male Infertility Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Male Infertility Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Male Infertility Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Male Infertility Treatment covered in this report include Merck Serono, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions and Livzon Pharmaceutical Group Inc., etc.
The global Male Infertility Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Serono
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions
Livzon Pharmaceutical Group Inc.
Zhejiang Xianju Pharmaceutical Co.,Ltd.
GeneScience Pharmaceuticals Co., Ltd.
Abeona Therapeutics Inc.
ASKA Pharmaceutical Co., Ltd.
Bristol Myers Squibb
Church & Dwight
Intas Biopharmaceuticals
Eli Lilly and Company
Global Male Infertility Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Male Infertility Treatment market, Segment by Type:
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Global Male Infertility Treatment market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Male Infertility Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Male Infertility Treatment
1.1 Male Infertility Treatment Market Overview
1.1.1 Male Infertility Treatment Product Scope
1.1.2 Male Infertility Treatment Market Status and Outlook
1.2 Global Male Infertility Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Male Infertility Treatment Market Size by Region (2018-2029)
1.4 Global Male Infertility Treatment Historic Market Size by Region (2018-2023)
1.5 Global Male Infertility Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Male Infertility Treatment Market Size (2018-2029)
1.6.1 North America Male Infertility Treatment Market Size (2018-2029)
1.6.2 Europe Male Infertility Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Male Infertility Treatment Market Size (2018-2029)
1.6.4 Latin America Male Infertility Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Male Infertility Treatment Market Size (2018-2029)
2 Male Infertility Treatment Market by Type
2.1 Introduction
2.1.1 DNA Fragmentation Technique
2.1.2 Oxidative Stress Analysis
2.1.3 Microscopic Examination
2.1.4 Sperm Agglutination
2.1.5 Computer Assisted Semen Analysis
2.1.6 Sperm Penetration Assay
2.2 Global Male Infertility Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Male Infertility Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Male Infertility Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Male Infertility Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Male Infertility Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Male Infertility Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Male Infertility Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Male Infertility Treatment Revenue Breakdown by Type (2018-2029)
3 Male Infertility Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Male Infertility Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Male Infertility Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Male Infertility Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Male Infertility Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Male Infertility Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Male Infertility Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Male Infertility Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Male Infertility Treatment Revenue Breakdown by Application (2018-2029)
4 Male Infertility Treatment Competition Analysis by Players
4.1 Global Male Infertility Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Male Infertility Treatment as of 2022)
4.3 Date of Key Players Enter into Male Infertility Treatment Market
4.4 Global Top Players Male Infertility Treatment Headquarters and Area Served
4.5 Key Players Male Infertility Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Male Infertility Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck Serono
5.1.1 Merck Serono Profile
5.1.2 Merck Serono Main Business
5.1.3 Merck Serono Male Infertility Treatment Products, Services and Solutions
5.1.4 Merck Serono Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Serono Recent Developments
5.2 Aytu BioScience
5.2.1 Aytu BioScience Profile
5.2.2 Aytu BioScience Main Business
5.2.3 Aytu BioScience Male Infertility Treatment Products, Services and Solutions
5.2.4 Aytu BioScience Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Aytu BioScience Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Male Infertility Treatment Products, Services and Solutions
5.3.4 Bayer Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Cadila Recent Developments
5.4 Cadila
5.4.1 Cadila Profile
5.4.2 Cadila Main Business
5.4.3 Cadila Male Infertility Treatment Products, Services and Solutions
5.4.4 Cadila Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Cadila Recent Developments
5.5 Intas Pharma
5.5.1 Intas Pharma Profile
5.5.2 Intas Pharma Main Business
5.5.3 Intas Pharma Male Infertility Treatment Products, Services and Solutions
5.5.4 Intas Pharma Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Intas Pharma Recent Developments
5.6 Halotech DNA
5.6.1 Halotech DNA Profile
5.6.2 Halotech DNA Main Business
5.6.3 Halotech DNA Male Infertility Treatment Products, Services and Solutions
5.6.4 Halotech DNA Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Halotech DNA Recent Developments
5.7 SCSA diagnostics
5.7.1 SCSA diagnostics Profile
5.7.2 SCSA diagnostics Main Business
5.7.3 SCSA diagnostics Male Infertility Treatment Products, Services and Solutions
5.7.4 SCSA diagnostics Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 SCSA diagnostics Recent Developments
5.8 Andrology Solutions
5.8.1 Andrology Solutions Profile
5.8.2 Andrology Solutions Main Business
5.8.3 Andrology Solutions Male Infertility Treatment Products, Services and Solutions
5.8.4 Andrology Solutions Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Andrology Solutions Recent Developments
5.9 Livzon Pharmaceutical Group Inc.
5.9.1 Livzon Pharmaceutical Group Inc. Profile
5.9.2 Livzon Pharmaceutical Group Inc. Main Business
5.9.3 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Products, Services and Solutions
5.9.4 Livzon Pharmaceutical Group Inc. Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Livzon Pharmaceutical Group Inc. Recent Developments
5.10 Zhejiang Xianju Pharmaceutical Co.,Ltd.
5.10.1 Zhejiang Xianju Pharmaceutical Co.,Ltd. Profile
5.10.2 Zhejiang Xianju Pharmaceutical Co.,Ltd. Main Business
5.10.3 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Products, Services and Solutions
5.10.4 Zhejiang Xianju Pharmaceutical Co.,Ltd. Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Zhejiang Xianju Pharmaceutical Co.,Ltd. Recent Developments
5.11 GeneScience Pharmaceuticals Co., Ltd.
5.11.1 GeneScience Pharmaceuticals Co., Ltd. Profile
5.11.2 GeneScience Pharmaceuticals Co., Ltd. Main Business
5.11.3 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Products, Services and Solutions
5.11.4 GeneScience Pharmaceuticals Co., Ltd. Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 GeneScience Pharmaceuticals Co., Ltd. Recent Developments
5.12 Abeona Therapeutics Inc.
5.12.1 Abeona Therapeutics Inc. Profile
5.12.2 Abeona Therapeutics Inc. Main Business
5.12.3 Abeona Therapeutics Inc. Male Infertility Treatment Products, Services and Solutions
5.12.4 Abeona Therapeutics Inc. Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Abeona Therapeutics Inc. Recent Developments
5.13 ASKA Pharmaceutical Co., Ltd.
5.13.1 ASKA Pharmaceutical Co., Ltd. Profile
5.13.2 ASKA Pharmaceutical Co., Ltd. Main Business
5.13.3 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Products, Services and Solutions
5.13.4 ASKA Pharmaceutical Co., Ltd. Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 ASKA Pharmaceutical Co., Ltd. Recent Developments
5.14 Bristol Myers Squibb
5.14.1 Bristol Myers Squibb Profile
5.14.2 Bristol Myers Squibb Main Business
5.14.3 Bristol Myers Squibb Male Infertility Treatment Products, Services and Solutions
5.14.4 Bristol Myers Squibb Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 Bristol Myers Squibb Recent Developments
5.15 Church & Dwight
5.15.1 Church & Dwight Profile
5.15.2 Church & Dwight Main Business
5.15.3 Church & Dwight Male Infertility Treatment Products, Services and Solutions
5.15.4 Church & Dwight Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Church & Dwight Recent Developments
5.16 Intas Biopharmaceuticals
5.16.1 Intas Biopharmaceuticals Profile
5.16.2 Intas Biopharmaceuticals Main Business
5.16.3 Intas Biopharmaceuticals Male Infertility Treatment Products, Services and Solutions
5.16.4 Intas Biopharmaceuticals Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.16.5 Intas Biopharmaceuticals Recent Developments
5.17 Eli Lilly and Company
5.17.1 Eli Lilly and Company Profile
5.17.2 Eli Lilly and Company Main Business
5.17.3 Eli Lilly and Company Male Infertility Treatment Products, Services and Solutions
5.17.4 Eli Lilly and Company Male Infertility Treatment Revenue (US$ Million) & (2018-2023)
5.17.5 Eli Lilly and Company Recent Developments
6 North America
6.1 North America Male Infertility Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Male Infertility Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Male Infertility Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Male Infertility Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Male Infertility Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Male Infertility Treatment Market Dynamics
11.1 Male Infertility Treatment Industry Trends
11.2 Male Infertility Treatment Market Drivers
11.3 Male Infertility Treatment Market Challenges
11.4 Male Infertility Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
